John Overdeck’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,800
Closed -$5.51M 4034
2021
Q4
$5.51M Buy
20,800
+15,700
+308% +$4.23M 0.01% 1143
2021
Q3
$1.47M Sell
5,100
-6,100
-54% -$1.56M ﹤0.01% 2259
2021
Q2
$2.24M Buy
11,200
+10,000
+833% +$1.94M 0.01% 1768
2021
Q1
$233K Buy
+1,200
New +$246K ﹤0.01% 3527
2020
Q4
Sell
-2,500
Closed -$369K 3686
2020
Q3
$369K Buy
+2,500
New +$357K ﹤0.01% 2454

Other funds holding RGEN

John Overdeck's RGEN Position: Q2 2026 in Review

John Overdeck opened a new position in Repligen (RGEN) in Q2 2026: 9,901 shares worth $1.35M. The stake represents ﹤0.01% of the portfolio and ranks #3372 among its holdings. This is a return to the name: John Overdeck previously reported a position in RGEN as recently as Q4 2025.

John Overdeck first reported a position in RGEN in Q2 2013 and has held it in 32 quarters since. The position peaked at $64.9M in Q3 2024. 476 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • John Overdeck held 9,901 shares of Repligen worth $1.35M as of Q2 2026.
  • Repligen was a new John Overdeck position in Q2 2026.
  • Repligen made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3372 holding.
  • John Overdeck first reported a position in Repligen in Q2 2013 and has held it in 32 quarters since.
  • John Overdeck's Repligen position peaked at $64.9M in Q3 2024.
  • 476 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.